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Abstract
Background The evaluation of contrast sensitivity is an im-
portant additional examination that allows the physician to
achieve the full picture of a patient's quality of vision. In low-
contrast conditions, more discrete visual dysfunctions may be
revealed, which could be overlooked in high-contrast tests.
Methods The examined group consisted of 33 eyes of 27
patients with multiple sclerosis. The study included patients
with full or almost full visual acuity, without visual field
defects or any other ophthalmic condition, and who had never
undergone any ocular surgery or trauma. The reference group
consisted of 49 eyes of 37 patients. This group included
healthy subjects with full visual acuity. Contrast sensitivity
was examined with a Functional Vision Analyzer™ device in
photopic conditions (with and without glare) and in mesopic
conditions (with and without glare).
Results In patients with multiple sclerosis who had experi-
enced optic neuritis, contrast sensitivity was found to be
significantly reduced in all spatial frequencies in both mesopic
and photopic conditions (with and without glare).
Conclusions Contrast sensitivity in patients with multiple
sclerosis who have also had optic neuritis is significantly
reduced. This may explain patients' complaints regarding their
quality of vision, despite good visual acuity. Contrastometry is
a useful basis for further examination, providing additional
information regarding a patient's quality of vision.
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Introduction
The evaluation of contrast sensitivity is an important exami-
nation that allows us to recognize many visual disfunctions in
their early stages and to achieve the full picture of a patient's
quality of vision [1–3]. In various diseases, the ability to
discern low-contrast objects may be decreased, while the
ability to recognize high-contrast objects may be unaffected.
During a routine ophthalmic examination, the evaluation of
visual acuity with Snellen or logMAR charts is one of basic
tests performed to examine visual functions. However, it is
necessary to be aware of the limitations of examinations using
these charts, as they are designed with high-contrast optotypes
[4–7].
In low-contrast conditions, more discrete visual dysfunc-
tions may be revealed that could be otherwise overlooked in
high-contrast tests [5, 8–15]. The evaluation of contrast sen-
sitivity is a subjective measurement of visual potential and
provides information about the quality of a patient's vision [3,
15].
In most life situations, we have contact with objects of
lower contrast than those on Snellen charts. For this reason,
the evaluation of contrast sensitivity allows us to understand
why among people with similar visual acuity, some patients
complain of decreased vision and visual functioning in every-
day life [13, 14, 16–19].
Contrastometry is used mainly to diagnose patients with
ophthalmic diseases or patients who have undergone refrac-
tive or cataract surgery, but it is also useful in the examination
of patients with neurological diseases, general medical condi-
tions, neurotoxical disorders, and of some healthy people, in
whom it is important to evaluate visual quality (e.g., pilots,
drivers, etc.).
Demyelinization in the course of multiple sclerosis (MS) is
one of the most frequent causes of optic neuritis. It is estimated
that about 15–20 % of patients with multiple sclerosis are
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diagnosed with optic neuritis in the course of the disease [1,
20]. There are articles suggesting that this proportion is much
higher and may be as high as 50 % [1, 21, 22]. The main
symptoms include: subacute, unilateral, and decreased visual
acuity, which may be accompanied by dyschromatopsy, de-
creased contrast sensitivity, phosphenes (positive visual phe-
nomena) seen as white or colorful flashes, as well as ocular
pain or pain around the eyeball, which increases with eye
movement and afferent pupillary defect. In addition, visual
field defects or, more frequently, generalized decreased retinal
sensitivity may be present. Decreased contrast sensitivity is
present in about 60–80 % of patients with MS; nevertheless,
some of them have normal visual acuity [23–25].
The purpose of our study was to evaluate contrast sensitiv-
ity in patients with multiple sclerosis who had also suffered
from optic neuritis, as well as to estimate the clinical useful-
ness of the Functional Vision Analyzer™ in the diagnostics of
these patients.
Methods
The examined group consisted of 33 eyes of 27 patients (10
men and 17 women), aged from 19 to 48 years old (mean
32 years), diagnosed with multiple sclerosis. The study in-
cluded only patients with good best-corrected visual acuity
(BCVA), ranging from 0.7 to 1.0 (mean BCVA=0.97) without
visual field defects or any other ophthalmic condition. Other
inclusion criteria were: the lack of any visual symptoms, no
ocular disease, no previous ocular surgery or trauma, as well
as the absence of any general medical conditions. In cases
when the patient experienced optic neuritis unilaterally, only
one eye was included in the study. The duration of multiple
sclerosis ranged from 1 to 16 years. The time between the
episode of optic neuritis and our contrast sensitivity measure-
ment exceeded 6 months in all cases.
The reference group consisted of 49 eyes of 37 patients (16
women and 21 men), aged from 20 to 81 years old (mean
43 years). This group included healthy subjects, with full
visual acuity, who had never been diagnosed with any oph-
thalmic disease.
The analyzed data were gathered prospectively from a non-
randomized consecutive series of patients. For all study pro-
tocols, we followed all tenets of the Declaration of Helsinki.
All patients gave an informed consent to participate in the
study. Before the study, the Ethics Committee approval was
obtained (number RNN/53/11/KE).
All patients had a full ophthalmic examination before
contrastometry was performed. Best-corrected visual acuity
was examined with standard Snellen charts (numeral
optotypes). Slit-lamp examination of the anterior segment
and the eye fundus was performed. Intraocular pressure was
measured with an applanation tonometer. In addition, retinal
nerve fiber layer (RNFL) thickness was measured using opti-
cal coherence tomography (OCT).
In all patients, contrast sensitivity was examined with a
Functional Vision Analyzer™ (Stereo Optical Co., Inc.) de-
vice in photopic conditions (with and without glare) and in
mesopic conditions (with and without glare). In all patients,
contrastometry was performed in the same lightning condi-
tions, with a "distance examination strategy". Patients who
had a refractive error were examined with appropriate
correction.
We also evaluated vision (with and without glare, 1 lux)
and day vision (with and without glare, 10 lux) in each patient,
for each eye separately. Contrast sensitivity was measured for
the following spatial frequencies: 1.5, 3, 6, 12, and 18 cpd
(cycles per degree).
Results
The results of contrast sensitivity measurements show that
there is a significant difference in the mean contrast sensitivity
between group of patients after optic neuritis in multiple
sclerosis and healthy subjects (Table 1). Furthermore, in pa-
tients with multiple sclerosis, contrast sensitivity is signifi-
cantly reduced in all spatial frequencies, both in photopic
conditions (with and without glare) and in mesopic conditions
(with and without glare) (Table 2).
Our study also confirms that a reduction of contrast sensi-
tivity is observable in all spatial frequencies—low, medium,
and high.
The results of OCT measurements in a group of patients
with multiple sclerosis show that retinal nerve fiber layer
thickness (RNFL) was between 56 and 122 μm (mean 98.3;
standard deviation 16.2). All patients with MS, except one,
had RNFL thickness above 75 μm. RNFL thickness in a
group of healthy control subjects was from 78 to 126 μm
(mean 100.9; standard deviation 14). There were no statisti-
cally significant differences between mean RNFL thickness in
both groups.
Discussion
Decreased contrast sensitivity is noticeable in low, intermedi-
ate, and high spatial frequencies in patients with an acute
inflammatory phase, in patients after neuritis, and in patients
with multiple sclerosis without a history of optic neuritis [23].
In patients who haven't had optic neuritis in the course of
multiple sclerosis, contrast sensitivity was decreased in inter-
mediate and high spatial frequencies (12–18 cpd) [26].
In patients with optic neuritis, an increase in visual acuity
can be observed after 2–4 weeks, to the level of 0.6 or better.
Nevertheless, color perception and contrast sensitivity are
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Table 1 Comparison of contrast
sensitivity measurements in vari-
ous conditions, in patients after
optic neuritis with the control
group




Group Z test Significance p
MS with optic neuritis Control group
x SD x SD
Night testing without
glare
1.5 31.9 12.1 56.0 25.1 4.515 p<0.001
3 70.4 32.9 104.3 34.7 3.990 p<0.001
6 34.3 23.4 69.3 33.5 4.577 p<0.001
12 8.45 7.52 21.4 16.4 4.174 p<0.001
18 0.91 2.50 4.76 4.48 4.005 p<0.001
Night testing with glare 1.5 39.9 19.2 65.7 23.9 4.477 p<0.001
3 72.1 34.2 109.0 31.2 4.298 p<0.001
6 35.9 27.7 68.4 30.8 4.709 p<0.001
12 9.79 8.34 20.9 15.5 3.744 p<0.001
18 0.61 1.97 4.82 5.13 4.094 p<0.001
Day testing without glare 1.5 28.6 12.7 50.4 19.3 5.238 p<0.001
3 79.7 33.4 117.1 27.9 4.553 p<0.001
6 52.6 30.5 108.0 38.7 5.569 p<0.001
12 22.1 14.4 41.3 24.4 3.995 p<0.001
18 6.42 5.40 16.2 11.5 4.189 p<0.001
Day testing with glare 1.5 40.2 15.8 64.3 23.6 4.392 p<0.001
3 84.9 30.9 127.4 26.1 5.064 p<0.001
6 59.9 39.1 112.3 37.9 5.201 p<0.001
12 25.9 20.0 47.0 25.8 4.028 p<0.001
18 7.15 6.01 17.5 12.5 3.971 p<0.001
Table 2 Statistics of contrast
sensitivity measurements, in
daylight/night conditions, with
and without glare, in patients after
optic neuritis
min minimum, max maximum, x





min max x Me SD v(%)
Night testing without glare 1.5 13 50 31.9 36 12.1 37.8
3 10 160 70.4 57 32.9 46.7
6 0 90 34.3 33 23.4 68.4
12 0 22 8.45 8 7.52 88.9
18 0 12 0.91 0 2.50 275.5
Night testing with glare 1.5 18 71 39.9 36 19.2 48.1
3 10 160 72.1 57 34.2 47.4
6 0 128 35.9 33 27.7 77.0
12 0 30 9.79 11 8.34 85.2
18 0 8 0.61 0 1.97 324.6
Day testing without glare 1.5 13 71 28.6 25 12.7 44.2
3 29 160 79.7 80 33.4 41.9
6 0 128 52.6 45 30.5 57.9
12 0 60 22.1 22 14.4 65.3
18 0 17 6.42 8 5.40 84.0
Day testing with glare 1.5 18 71 40.2 36 15.8 39.3
3 29 160 84.9 80 30.9 36.4
6 0 180 59.9 45 39.1 65.3
12 0 85 25.9 22 20.0 77.3
18 0 17 7.15 8 6.01 84.0
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reduced. In about 10 % of patients, chronic optic neuritis
develops, with no remissions and with a constant and gradual
decrease of visual acuity [1, 20, 27–31].
Degeneration of the optic nerve axons causes the distur-
bance of retinal nerve fiber layer thickness, which can be
documented with OCT. What's more, OCTallows an estimate
of the relationship between RNFL thickness and visual func-
tion after optic neuritis. It is thought that the first changes in
RNFL thickness can be seen in the temporal quadrant, as early
as 2 months after the inflammatory episode. The decrease in
RNFL thickness in eyes after optic neuritis is visible for up to
24months; during the first 6 months the changes increase, and
later on, they stabilize [32].
Regression analysis helped to determine the minimal
RNFL thickness (amounting to 75 μm) that allowed for the
recovery of vision after optic neuritis [32, 33]. Retinal nerve
fiber thickness was found to correlate with visual acuity,
contrast sensitivity, color vision, and visual field defects [20].
There was a significant decrease of RNFL thickness in eyes
after optic neuritis caused by multiple sclerosis, in comparison
with the fellow eye and with healthy subjects. In addition, an
RNFL below 75 μm was significantly correlated with visual
field defects. It has been observed that despite the fact that
visual acuity returned to normal after optic neuritis, patients
still complain of subjective decreased vision, which may
result from decreased contrast sensitivity or visual field de-
fects [21, 31, 34].
There are few characteristic types of changes in contrast
sensitivity in patients who had optic neuritis in multiple scle-
rosis: (1) decreased contrast sensitivity in all spatial frequen-
cies; (2) decreased contrast sensitivity in intermediate and
high spatial frequencies; (3) decreased contrast sensitivity in
only intermediate spatial frequencies; (4) decreased contrast
sensitivity in only low spatial frequencies; and (5) unchanged
contrast sensitivity [31]. The last two types mentioned are the
least frequently encountered.
In examinations evaluating color vision and contrast sensi-
tivity in patients with multiple sclerosis, it has been observed
that defects may be selective or generalized. Dain et al. [29]
proved the existence of two outcomes among patients after
optic neuritis. The first group had a selective defect of color
vision in the red-green axis, as well as selective impairment of
contrast sensitivity in high spatial frequencies. The second
group had a generalized defect of color vision, concerning
both the red-green axis and blue-yellow axis, as well as a
generalized impairment of contrast sensitivity irrespective of
spatial frequency. The authors conclude that this phenomenon
may result from the demyelinative damage to the optic nerve,
which may be either selective and include mainly small axons,
or that it may be generalized and include both small and large
axons.
Rekas et al. [35] draw similar conclusions regarding selec-
tive and non-selective damage to the optic nerve in patients
with multiple sclerosis. They found that one group of patients
had decreased contrast sensitivity at 18 cpd, as well as
defective blue-color perception, whereas the second group
of patients had decreased contrast sensitivity at 12 cpd, as
well as defective red-color perception. In the third (and the
largest) group of patients, there was a generalized (non-
selective) defect in color perception and generalized de-
creased contrast sensitivity, with a predilection for higher
spatial frequencies.
The results of our study are consistent with the results of
previously published articles. However, we have performed a
full evaluation of contrast sensitivity in photopic conditions
(with and without glare), as well as in mesopic conditions
(with and without glare) in patients withMS, which revealed a
non-selective significant reduction of contrast sensitivity. Fur-
thermore, this study emphasizes the important role of
contrastometry in patients with MS, as a method that can
identify the deficits of visual function that otherwise go
undetected by a simple visual acuity measurement.
Conclusions
Contrast sensitivity in patients with multiple sclerosis who
also suffer from optic neuritis is significantly reduced in all
spatial frequencies, both in photopic conditions (with and
without glare) and in mesopic conditions (with and without
glare). This may explain patients' complaints regarding their
quality of vision, despite having good visual acuity.
Contrastometry is a useful basis for examination in this
context, providing additional information regarding the
patient's quality of vision.
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